Do human myeloma cells directly produce the receptor activator of nuclear factor kappaB ligand (RANKL) or induce RANKL in the bone marrow microenvironment?
Giuliani
Nicola
N
Colla
Simona
S
Rizzoli
Vittorio
V
Barillé-Nion
Sophie
S
Bataille
Régis
R
D001854:Bone Marrow Cells / Q000473:pathology*; D002352:Carrier Proteins / Q000235:genetics*; D016207:Cytokines / Q000235:genetics; D006801:Humans; D008024:Ligands; D008562:Membrane Glycoproteins / Q000235:genetics*; D009101:Multiple Myeloma / Q000235:genetics* / Q000473:pathology; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B
D002352:Carrier Proteins; D016207:Cytokines; D008024:Ligands; D008562:Membrane Glycoproteins; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; C505686:TNFRSF11A protein, human; C505688:TNFSF11 protein, human